BioCina Pty Ltd., a global end-to-end biologics contract development and manufacturing organization (CDMO), announced the expansion of their partnership with GPN Vaccines Ltd. GPN Vaccines is a biotechnology company developing a proprietary engineered whole-cell vaccine called Gamma-PN™ against Streptococcus pneumoniae. This bacterium is responsible for causing life-threatening infections such as pneumonia, bacteraemia and meningitis, each year causing up to 2 million deaths worldwide. GPN's vac
In a groundbreaking development, a potential pneumonia vaccine developed by researchers from the University of Oklahoma's College of Medicine is undergoing clin
There's a new vaccine candidate to protect people against the pneumonia, and it was developed right here in Oklahioma.A researcher at OU's College of Medicine d